Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for FRAGMIN
- Prolonged Hypercoagulability Following Major Liver Resection for Malignancy
- A Study to Evaluate Dimolegin in Prevention of Thromboembolic Complications During Knee Replacement
- A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE
- Thromboprophylaxis in Oesophageal Cancer Patients
- Causes and Prevention of Thromboembolic Disease in Nephrotic Syndrome
- PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST)
- A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism
- Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
- Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery
- Use Of Fragmin In Hemodialysis
- Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy
- Preoperative Versus Postoperative Start With Thromboprophylaxis in THA (Total Hip Arthroplasty)
- Heparin Anticoagulation to Improve Outcomes in Septic Shock: The HALO Pilot
- Dalteparin, Lenalidomide, and Low-Dose Dexamethasone in Treating Patients With Previously Untreated Multiple Myeloma
- PROSPER: PostpaRtum PrOphylaxiS for PE Randomized Control Trial Pilot
- Efficacy of Low Molecular Weight Heparin in Superficial Vein Thrombosis
- The Clinical Utility of Thrombelastography in Guiding Prophylaxis of Venous Thromboembolism Following Trauma
- An Observational Study On The Safety And Tolerability Of Prolonged Thrombosis Prophylaxis With Fragmin®
- TIPPS: Thrombophilia in Pregnancy Prophylaxis Study
- Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients
- Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients
- Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer
- A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
- A Cohort Study With 100 Subjects Having a Primary Total Knee Replacement, Taking Pradax Post Discharge for Ten Days
- Effectiveness of Bridging Anticoagulation for Surgery (The BRIDGE Study)
- The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients (A6301086)
- Alterations of Blood Clotting With the Use of Sequential Compression Devices on the Lower Limbs
- Study Of The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients
- Dalteparin in Preventing DVT in Participants With Cancer
- Dalteparin in Preventing Blood Clots in Patients With Lung Cancer
- Fragmin In The Treatment Of Acute Deep-Vein Thrombosis With Or Without Pulmonary Embolism In Cancer Patients
- PERIOP 2 - A Safety and Effectiveness of LMWH vs Placebo Bridging Therapy for Patients on Long Term Warfarin Requiring Temporary Interruption of Warfarin.
- Management of Superficial Thrombophlebitis
- Treatment of Upper Extremity Deep-Vein Thrombosis
- Fragmin in Ovarian Cancer: Utility on Survival (FOCUS)
- PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT)
- Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients
- Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter
Clinical trials list
click for details